172 related articles for article (PubMed ID: 36770840)
1. 3-Arylidene-2-oxindoles as Potent NRH:Quinone Oxidoreductase 2 Inhibitors.
Lozinskaya NA; Bezsonova EN; Dubar M; Melekhina DD; Bazanov DR; Bunev AS; Grigor'eva OB; Klochkov VG; Sokolova EV; Babkov DA; Spasov AA; Sosonyuk SE
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770840
[TBL] [Abstract][Full Text] [Related]
2. NRH:quinone oxidoreductase 2 (NQO2) catalyzes metabolic activation of quinones and anti-tumor drugs.
Celli CM; Tran N; Knox R; Jaiswal AK
Biochem Pharmacol; 2006 Jul; 72(3):366-76. PubMed ID: 16765324
[TBL] [Abstract][Full Text] [Related]
3. Reduction and Scavenging of Chemically Reactive Drug Metabolites by NAD(P)H:Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 and Variability in Hepatic Concentrations.
den Braver-Sewradj SP; den Braver MW; Toorneman RM; van Leeuwen S; Zhang Y; Dekker SJ; Vermeulen NPE; Commandeur JNM; Vos JC
Chem Res Toxicol; 2018 Feb; 31(2):116-126. PubMed ID: 29281794
[TBL] [Abstract][Full Text] [Related]
4. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
[TBL] [Abstract][Full Text] [Related]
5. Indolequinone inhibitors of NRH:quinone oxidoreductase 2. Characterization of the mechanism of inhibition in both cell-free and cellular systems.
Yan C; Dufour M; Siegel D; Reigan P; Gomez J; Shieh B; Moody CJ; Ross D
Biochemistry; 2011 Aug; 50(31):6678-88. PubMed ID: 21718050
[TBL] [Abstract][Full Text] [Related]
6. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.
Wu K; Knox R; Sun XZ; Joseph P; Jaiswal AK; Zhang D; Deng PS; Chen S
Arch Biochem Biophys; 1997 Nov; 347(2):221-8. PubMed ID: 9367528
[TBL] [Abstract][Full Text] [Related]
7. The two common polymorphic forms of human NRH-quinone oxidoreductase 2 (NQO2) have different biochemical properties.
Megarity CF; Gill JR; Caraher MC; Stratford IJ; Nolan KA; Timson DJ
FEBS Lett; 2014 May; 588(9):1666-72. PubMed ID: 24631540
[TBL] [Abstract][Full Text] [Related]
8. NRH:quinone oxidoreductase 2 (NQO2) and glutaminase (GLS) both play a role in large extracellular vesicles (LEV) formation in preclinical LNCaP-C4-2B prostate cancer model of progressive metastasis.
Dorai T; Shah A; Summers F; Mathew R; Huang J; Hsieh TC; Wu JM
Prostate; 2018 Nov; 78(15):1181-1195. PubMed ID: 30009389
[TBL] [Abstract][Full Text] [Related]
9. Novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2): crystal structures, biochemical activity, and intracellular effects of imidazoacridin-6-ones.
Dunstan MS; Barnes J; Humphries M; Whitehead RC; Bryce RA; Leys D; Stratford IJ; Nolan KA
J Med Chem; 2011 Oct; 54(19):6597-611. PubMed ID: 21859103
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of NRH:quinone oxidoreductase 2 differentially regulates TNF signaling in keratinocytes: up-regulation of apoptosis correlates with down-regulation of cell survival kinases.
Ahn KS; Gong X; Sethi G; Chaturvedi MM; Jaiswal AK; Aggarwal BB
Cancer Res; 2007 Oct; 67(20):10004-11. PubMed ID: 17942934
[TBL] [Abstract][Full Text] [Related]
11. Molecular Pharmacology of NRH:Quinone Oxidoreductase 2: A Detoxifying Enzyme Acting as an Undercover Toxifying Enzyme.
Janda E; Nepveu F; Calamini B; Ferry G; Boutin JA
Mol Pharmacol; 2020 Nov; 98(5):620-633. PubMed ID: 32913139
[No Abstract] [Full Text] [Related]
12. Discovery of potent 4-aminoquinoline hydrazone inhibitors of NRH:quinoneoxidoreductase-2 (NQO2).
Hussein B; Ikhmais B; Kadirvel M; Magwaza RN; Halbert G; Bryce RA; Stratford IJ; Freeman S
Eur J Med Chem; 2019 Nov; 182():111649. PubMed ID: 31514018
[TBL] [Abstract][Full Text] [Related]
13. Interactions of the antioxidant enzymes NAD(P)H: Quinone oxidoreductase 1 (NQO1) and NRH: Quinone oxidoreductase 2 (NQO2) with pharmacological agents, endogenous biochemicals and environmental contaminants.
Rashid MH; Babu D; Siraki AG
Chem Biol Interact; 2021 Aug; 345():109574. PubMed ID: 34228969
[TBL] [Abstract][Full Text] [Related]
14. Evidence for NQO1 and NQO2 catalyzed reduction of ortho- and para-quinone methides.
Kucera HR; Livingstone M; Moscoso CG; Gaikwad NW
Free Radic Res; 2013 Dec; 47(12):1016-26. PubMed ID: 24074361
[TBL] [Abstract][Full Text] [Related]
15. NRH:quinone oxidoreductase2 (NQO2).
Long DJ; Jaiswal AK
Chem Biol Interact; 2000 Dec; 129(1-2):99-112. PubMed ID: 11154737
[TBL] [Abstract][Full Text] [Related]
16. Differential gene expression of NAD(P)H:quinone oxidoreductase and NRH:quinone oxidoreductase in human hepatocellular and biliary tissue.
Strassburg A; Strassburg CP; Manns MP; Tukey RH
Mol Pharmacol; 2002 Feb; 61(2):320-5. PubMed ID: 11809856
[TBL] [Abstract][Full Text] [Related]
17. Mechanism-based inhibition of quinone reductase 2 (NQO2): selectivity for NQO2 over NQO1 and structural basis for flavoprotein inhibition.
Dufour M; Yan C; Siegel D; Colucci MA; Jenner M; Oldham NJ; Gomez J; Reigan P; Li Y; De Matteis CI; Ross D; Moody CJ
Chembiochem; 2011 May; 12(8):1203-8. PubMed ID: 21506232
[TBL] [Abstract][Full Text] [Related]
18. Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones.
Gaikwad NW; Yang L; Rogan EG; Cavalieri EL
Free Radic Biol Med; 2009 Jan; 46(2):253-62. PubMed ID: 18996184
[TBL] [Abstract][Full Text] [Related]
19. In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2).
Nolan KA; Caraher MC; Humphries MP; Bettley HA; Bryce RA; Stratford IJ
Bioorg Med Chem Lett; 2010 Dec; 20(24):7331-6. PubMed ID: 21074425
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms and Pharmacogenomics of
Janda E; Boutin JA; De Lorenzo C; Arbitrio M
Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38254976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
